1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2 EUROPE PROFESSIONAL ACNE MEDICATION MARKET – EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT, 2023 - 2030, MILLION USD
3 PORTER’S FIVE FORCE MODEL ANALYSIS
3.1 BARGAINING POWER OF SUPPLIERS
3.2 BARGAINING POWER OF BUYERS
3.3 DEGREE OF COMPETITION
3.4 THREAT OF SUBSTITUTE
3.5 THREAT OF NEW ENTRANTS
4 MARKET SHARE ANALYSIS
4.1 MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023
5 MARKET DYNAMICS
5.1 GROWTH DRIVERS
5.1.1 DRIVER 1
5.1.2 DRIVER 2
5.1.3 DRIVER 3
5.1.4 DRIVER 4
5.2 CHALLENGES
5.2.1 CHALLENGE 1
5.2.2 CHALLENGE 2
5.2.3 CHALLENGE 3
5.2.4 CHALLENGE 4
5.3 OPPORTUNITIES
5.3.1 OPPORTUNITY 1
5.3.2 OPPORTUNITY 2
6 EUROPE PROFESSIONAL ACNE MEDICATION MARKET BY ACNE TYPE
6.1 OVERVIEW
6.2 INFLAMMATORY ACNE
6.2.1 INFLAMMATORY ACNE MARKET, BY COUNTRY
6.3 NON-INFLAMMATORY ACNE
6.3.1 NON-INFLAMMATORY ACNE MARKET, BY COUNTRY
7 EUROPE PROFESSIONAL ACNE MEDICATION MARKET BY FORMULATION
7.1 OVERVIEW
7.2 TOPICAL MEDICATIONS
7.2.1 TOPICAL MEDICATIONS MARKET, BY COUNTRY
7.3 ORAL MEDICATIONS
7.3.1 ORAL MEDICATIONS MARKET, BY COUNTRY
8 EUROPE PROFESSIONAL ACNE MEDICATION MARKET BY THERAPEUTIC CLASS
8.1 OVERVIEW
8.2 RETINOIDS
8.2.1 RETINOIDS MARKET, BY COUNTRY
8.3 ANTIBIOTICS
8.3.1 ANTIBIOTICS MARKET, BY COUNTRY
8.4 SALICYLIC ACID
8.4.1 SALICYLIC ACID MARKET, BY COUNTRY
8.5 BENZOYL PEROXIDE
8.5.1 BENZOYL PEROXIDE MARKET, BY COUNTRY
8.6 OTHERS
8.6.1 OTHERS MARKET, BY COUNTRY
9 EUROPE PROFESSIONAL ACNE MEDICATION MARKET BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 MED SPA
9.2.1 MED SPA MARKET, BY COUNTRY
9.3 AESTHETICIAN
9.3.1 AESTHETICIAN MARKET, BY COUNTRY
9.4 DERMATOLOGIST
9.4.1 DERMATOLOGIST MARKET, BY COUNTRY
9.5 OTHER PROFESSIONAL CHANNELS
9.5.1 OTHER PROFESSIONAL CHANNELS MARKET, BY COUNTRY
10 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY COUNTRY
10.1 OVERVIEW
10.2 GERMANY
10.2.1 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE
10.2.2 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION
10.2.3 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
10.2.4 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
10.3 FRANCE
10.3.1 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE
10.3.2 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION
10.3.3 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
10.3.4 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
10.4 ITALY
10.4.1 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE
10.4.2 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION
10.4.3 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
10.4.4 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
10.5 SPAIN
10.5.1 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE
10.5.2 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION
10.5.3 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
10.5.4 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
10.6 UNITED KINGDOM
10.6.1 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE
10.6.2 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION
10.6.3 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
10.6.4 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
10.7 NETHERLANDS
10.7.1 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE
10.7.2 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION
10.7.3 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
10.7.4 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
10.8 REST OF EUROPE
10.8.1 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE
10.8.2 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION
10.8.3 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
10.8.4 EUROPE PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11 COMPANY PROFILES
11.1 ALMIRALL S.A.
11.1.1 COMPANY OVERVIEW
11.1.2 COMPANY SNAPSHOT
11.1.3 OPERATING BUSINESS SEGMENTS
11.1.4 PRODUCT PORTFOLIO
11.1.5 BUSINESS PERFORMANCE
11.1.6 BUSINESS SEGMENTS
11.1.7 GEOGRAPHIC SEGMENTS
11.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.1.9 PRIMARY MARKET COMPETITORS
11.2 BAUSCH HEALTH COMPANIES, INC.
11.2.1 COMPANY OVERVIEW
11.2.2 COMPANY SNAPSHOT
11.2.3 OPERATING BUSINESS SEGMENTS
11.2.4 PRODUCT PORTFOLIO
11.2.5 BUSINESS PERFORMANCE
11.2.6 BUSINESS SEGMENTS
11.2.7 GEOGRAPHIC SEGMENTS
11.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.2.9 PRIMARY MARKET COMPETITORS
11.3 GLAXOSMITHKLINE PLC (GSK)
11.3.1 COMPANY OVERVIEW
11.3.2 COMPANY SNAPSHOT
11.3.3 OPERATING BUSINESS SEGMENTS
11.3.4 PRODUCT PORTFOLIO
11.3.5 BUSINESS PERFORMANCE
11.3.6 BUSINESS SEGMENTS
11.3.7 GEOGRAPHIC SEGMENTS
11.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.3.9 PRIMARY MARKET COMPETITORS
11.4 GALDERMA S.A.
11.4.1 COMPANY OVERVIEW
11.4.2 COMPANY SNAPSHOT
11.4.3 OPERATING BUSINESS SEGMENTS
11.4.4 PRODUCT PORTFOLIO
11.4.5 BUSINESS PERFORMANCE
11.4.6 BUSINESS SEGMENTS
11.4.7 GEOGRAPHIC SEGMENTS
11.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.4.9 PRIMARY MARKET COMPETITORS
11.5 SUN PHARMACEUTICAL INDUSTRIES LIMITED
11.5.1 COMPANY OVERVIEW
11.5.2 COMPANY SNAPSHOT
11.5.3 OPERATING BUSINESS SEGMENTS
11.5.4 PRODUCT PORTFOLIO
11.5.5 BUSINESS PERFORMANCE
11.5.6 BUSINESS SEGMENTS
11.5.7 GEOGRAPHIC SEGMENTS
11.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.5.9 PRIMARY MARKET COMPETITORS
11.6 TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.6.1 COMPANY OVERVIEW
11.6.2 COMPANY SNAPSHOT
11.6.3 OPERATING BUSINESS SEGMENTS
11.6.4 PRODUCT PORTFOLIO
11.6.5 BUSINESS PERFORMANCE
11.6.6 BUSINESS SEGMENTS
11.6.7 GEOGRAPHIC SEGMENTS
11.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.6.9 PRIMARY MARKET COMPETITORS
11.7 JOHNSON AND JOHNSON
11.7.1 COMPANY OVERVIEW
11.7.2 COMPANY SNAPSHOT
11.7.3 OPERATING BUSINESS SEGMENTS
11.7.4 PRODUCT PORTFOLIO
11.7.5 BUSINESS PERFORMANCE
11.7.6 BUSINESS SEGMENTS
11.7.7 GEOGRAPHIC SEGMENTS
11.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.7.9 PRIMARY MARKET COMPETITORS
11.8 ELI LILLY AND COMPANY
11.8.1 COMPANY OVERVIEW
11.8.2 COMPANY SNAPSHOT
11.8.3 OPERATING BUSINESS SEGMENTS
11.8.4 PRODUCT PORTFOLIO
11.8.5 BUSINESS PERFORMANCE
11.8.6 BUSINESS SEGMENTS
11.8.7 GEOGRAPHIC SEGMENTS
11.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.8.9 PRIMARY MARKET COMPETITORS
11.9 MYLAN N.V.
11.9.1 COMPANY OVERVIEW
11.9.2 COMPANY SNAPSHOT
11.9.3 OPERATING BUSINESS SEGMENTS
11.9.4 PRODUCT PORTFOLIO
11.9.5 BUSINESS PERFORMANCE
11.9.6 BUSINESS SEGMENTS
11.9.7 GEOGRAPHIC SEGMENTS
11.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.9.9 PRIMARY MARKET COMPETITORS
11.10 DAIICHI SANKYO COMPANY, LTD
11.10.1 COMPANY OVERVIEW
11.10.2 COMPANY SNAPSHOT
11.10.3 OPERATING BUSINESS SEGMENTS
11.10.4 PRODUCT PORTFOLIO
11.10.5 BUSINESS PERFORMANCE
11.10.6 BUSINESS SEGMENTS
11.10.7 GEOGRAPHIC SEGMENTS
11.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
11.10.9 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 2. INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 3. NON-INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 4. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 5. TOPICAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 6. ORAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 7. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 8. RETINOIDS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 9. ANTIBIOTICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 10. SALICYLIC ACID, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 11. BENZOYL PEROXIDE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 12. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 13. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 14. MED SPA, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 15. AESTHETICIAN, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 16. DERMATOLOGIST, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 17. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 18. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 19. GERMANY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 20. GERMANY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 21. GERMANY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 22. GERMANY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 23. FRANCE EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 24. FRANCE EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 25. FRANCE EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 26. FRANCE EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 27. ITALY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 28. ITALY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 29. ITALY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 30. ITALY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 31. SPAIN EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 32. SPAIN EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 33. SPAIN EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 34. SPAIN EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 35. UNITED KINGDOM EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 36. UNITED KINGDOM EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 37. UNITED KINGDOM EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 38. UNITED KINGDOM EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 39. NETHERLANDS EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 40. NETHERLANDS EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 41. NETHERLANDS EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 42. NETHERLANDS EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 43. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 44. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 45. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 46. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 47. ALMIRALL S.A.: COMPANY SNAPSHOT
TABLE 48. ALMIRALL S.A.: OPERATING BUSINESS SEGMENTS
TABLE 49. ALMIRALL S.A.: PRODUCT PORTFOLIO
TABLE 50. ALMIRALL S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 51. ALMIRALL S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 52. ALMIRALL S.A.: KEY STRATERGY
TABLE 53. BAUSCH HEALTH COMPANIES, INC.: COMPANY SNAPSHOT
TABLE 54. BAUSCH HEALTH COMPANIES, INC.: OPERATING BUSINESS SEGMENTS
TABLE 55. BAUSCH HEALTH COMPANIES, INC.: PRODUCT PORTFOLIO
TABLE 56. BAUSCH HEALTH COMPANIES, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 57. BAUSCH HEALTH COMPANIES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 58. BAUSCH HEALTH COMPANIES, INC.: KEY STRATERGY
TABLE 59. GLAXOSMITHKLINE PLC (GSK): COMPANY SNAPSHOT
TABLE 60. GLAXOSMITHKLINE PLC (GSK): OPERATING BUSINESS SEGMENTS
TABLE 61. GLAXOSMITHKLINE PLC (GSK): PRODUCT PORTFOLIO
TABLE 62. GLAXOSMITHKLINE PLC (GSK): SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 63. GLAXOSMITHKLINE PLC (GSK): SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 64. GLAXOSMITHKLINE PLC (GSK): KEY STRATERGY
TABLE 65. GALDERMA S.A.: COMPANY SNAPSHOT
TABLE 66. GALDERMA S.A.: OPERATING BUSINESS SEGMENTS
TABLE 67. GALDERMA S.A.: PRODUCT PORTFOLIO
TABLE 68. GALDERMA S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 69. GALDERMA S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 70. GALDERMA S.A.: KEY STRATERGY
TABLE 71. SUN PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT
TABLE 72. SUN PHARMACEUTICAL INDUSTRIES LIMITED: OPERATING BUSINESS SEGMENTS
TABLE 73. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO
TABLE 74. SUN PHARMACEUTICAL INDUSTRIES LIMITED: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 75. SUN PHARMACEUTICAL INDUSTRIES LIMITED: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 76. SUN PHARMACEUTICAL INDUSTRIES LIMITED: KEY STRATERGY
TABLE 77. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 78. TEVA PHARMACEUTICAL INDUSTRIES LTD.: OPERATING BUSINESS SEGMENTS
TABLE 79. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 80. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 81. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 82. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATERGY
TABLE 83. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 84. JOHNSON AND JOHNSON: OPERATING BUSINESS SEGMENTS
TABLE 85. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 86. JOHNSON AND JOHNSON: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 87. JOHNSON AND JOHNSON: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 88. JOHNSON AND JOHNSON: KEY STRATERGY
TABLE 89. ELI LILLY AND COMPANY: COMPANY SNAPSHOT
TABLE 90. ELI LILLY AND COMPANY: OPERATING BUSINESS SEGMENTS
TABLE 91. ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
TABLE 92. ELI LILLY AND COMPANY: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 93. ELI LILLY AND COMPANY: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 94. ELI LILLY AND COMPANY: KEY STRATERGY
TABLE 95. MYLAN N.V.: COMPANY SNAPSHOT
TABLE 96. MYLAN N.V.: OPERATING BUSINESS SEGMENTS
TABLE 97. MYLAN N.V.: PRODUCT PORTFOLIO
TABLE 98. MYLAN N.V.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 99. MYLAN N.V.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 100. MYLAN N.V.: KEY STRATERGY
TABLE 101. DAIICHI SANKYO COMPANY, LTD: COMPANY SNAPSHOT
TABLE 102. DAIICHI SANKYO COMPANY, LTD: OPERATING BUSINESS SEGMENTS
TABLE 103. DAIICHI SANKYO COMPANY, LTD: PRODUCT PORTFOLIO
TABLE 104. DAIICHI SANKYO COMPANY, LTD: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 105. DAIICHI SANKYO COMPANY, LTD: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 106. DAIICHI SANKYO COMPANY, LTD: KEY STRATERGY
LIST OF FIGURES
FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
FIGURE 7. INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 8. NON-INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 9. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
FIGURE 10. TOPICAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 11. ORAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 12. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
FIGURE 13. RETINOIDS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 14. ANTIBIOTICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 15. SALICYLIC ACID, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 16. BENZOYL PEROXIDE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 17. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 18. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
FIGURE 19. MED SPA, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 20. AESTHETICIAN, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 21. DERMATOLOGIST, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 22. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 23. EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY REGION 2023-2030, (MILLION USD)
FIGURE 24. GERMANY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)
FIGURE 25. GERMANY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)
FIGURE 26. GERMANY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)
FIGURE 27. GERMANY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)
FIGURE 28. FRANCE EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)
FIGURE 29. FRANCE EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)
FIGURE 30. FRANCE EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)
FIGURE 31. FRANCE EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)
FIGURE 32. ITALY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)
FIGURE 33. ITALY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)
FIGURE 34. ITALY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)
FIGURE 35. ITALY EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)
FIGURE 36. SPAIN EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)
FIGURE 37. SPAIN EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)
FIGURE 38. SPAIN EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)
FIGURE 39. SPAIN EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)
FIGURE 40. UNITED KINGDOM EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)
FIGURE 41. UNITED KINGDOM EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)
FIGURE 42. UNITED KINGDOM EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)
FIGURE 43. UNITED KINGDOM EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)
FIGURE 44. NETHERLANDS EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)
FIGURE 45. NETHERLANDS EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)
FIGURE 46. NETHERLANDS EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)
FIGURE 47. NETHERLANDS EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)
FIGURE 48. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)
FIGURE 49. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)
FIGURE 50. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)
FIGURE 51. REST OF EUROPE PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)
FIGURE 52. ALMIRALL S.A.: NET SALES, (2021-2023)
FIGURE 53. ALMIRALL S.A.: PRIMARY MARKET COMPETITORS
FIGURE 54. BAUSCH HEALTH COMPANIES, INC.: NET SALES, (2021-2023)
FIGURE 55. BAUSCH HEALTH COMPANIES, INC.: PRIMARY MARKET COMPETITORS
FIGURE 56. GLAXOSMITHKLINE PLC (GSK): NET SALES, (2021-2023)
FIGURE 57. GLAXOSMITHKLINE PLC (GSK): PRIMARY MARKET COMPETITORS
FIGURE 58. GALDERMA S.A.: NET SALES, (2021-2023)
FIGURE 59. GALDERMA S.A.: PRIMARY MARKET COMPETITORS
FIGURE 60. SUN PHARMACEUTICAL INDUSTRIES LIMITED: NET SALES, (2021-2023)
FIGURE 61. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRIMARY MARKET COMPETITORS
FIGURE 62. TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET SALES, (2021-2023)
FIGURE 63. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRIMARY MARKET COMPETITORS
FIGURE 64. JOHNSON AND JOHNSON: NET SALES, (2021-2023)
FIGURE 65. JOHNSON AND JOHNSON: PRIMARY MARKET COMPETITORS
FIGURE 66. ELI LILLY AND COMPANY: NET SALES, (2021-2023)
FIGURE 67. ELI LILLY AND COMPANY: PRIMARY MARKET COMPETITORS
FIGURE 68. MYLAN N.V.: NET SALES, (2021-2023)
FIGURE 69. MYLAN N.V.: PRIMARY MARKET COMPETITORS
FIGURE 70. DAIICHI SANKYO COMPANY, LTD: NET SALES, (2021-2023)
FIGURE 71. DAIICHI SANKYO COMPANY, LTD: PRIMARY MARKET COMPETITORS